İstanbul University Cerrahpasa Medical Faculty Pediatric Hematology and
2 İstanbul University Cerrahpasa Medical Faculty Radiology Dept.
3 İstanbul University Cerrahpasa Medical Faculty Pathology Dept.
4 Akdeniz University Medical Faculty Statistics Dept.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
To review a single center outcome of patients with Langerhans Cell
Histiocytosis diagnosed at a tertiary referral hospital from Turkey.
Materials and Methods
|Table 1. General Characteristics of patients, treatment and survival outcomes.|
|Table 2. Status of patients in relation to age.|
|Table 3. Treatment Options according to the involvement of disease.|
|Table 4. Univariate analysis of Factors Correlated With Overall Survival.|
|Figure 1. Kaplan Meier analysis of overall survival for patients.|
|Figure 2. Kaplan Meier analysis of event free survival for patients.|
|Figure 3. Kaplan Meier analysis of overall survival for patients according to risk groups. SS, single system; MS-RO-, multi system without risk organ involvement; MS-RO+, multi system with risk organ involvement.|